Opinion

Video

Payer and Reimbursement Considerations for Bispecific Therapies

Experts discuss how payer and reimbursement considerations affect access to bispecific therapies in different practice settings.

Video content above is prompted by the following:

How do payer and reimbursement considerations affect access to bispecific therapies in different practice settings?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Andrew Kuykendall, MD, Moffitt Cancer Center
Dr Sundar Jagannath
4 experts in this video
4 experts in this video
Screenshot of a webinar panel discussion with Viet Le, PA-C; Nathan Wong, PhD, MPH; Alison Bailey, MD; and Martha Gulati, MD, MS
World Hepatitis Day graphic | Image Credit: uazzal - stock.adobe.com
2 experts in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo